$27.28
0.421.56%
Ult. Agg.: Oct 30, 7:59 PM
Viking Therapeutics (VKTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.05 | $-1.21 | $-0.92 | $-0.90 |
| Actual | $-1.55 | $-1.10 | $-1.37 | $-1.38 |
| Surprise | -47.6% | +9.09% | -48.9% | -53.3% |
| Revenue | ||||
| Estimate | — | — | — | $10.0M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.28 | $-1.25 | $-0.79 | $-0.76 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $-1.55 | $-1.05 | -47.6 % |
| Q2 | Jul 29, 2026 | $-1.10 | $-1.21 | 9.09 % |
| Q1 | Apr 29, 2026 | $-1.37 | $-0.92 | -48.9 % |
| Q4 | Feb 11, 2026 | $-1.38 | $-0.90 | -53.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | Feb 11, 2026 | $0 | $10.00M | -100.0 % |